From 18 to 20 March 2026, the International Haemovigilance Network (IHN) Symposium was held at the Hotel Quirinale in Rome.

This biennial event, organised by the IHN in collaboration with the National Blood Centre (Centro Nazionale Sangue), represents the leading international meeting in the field of haemovigilance. It brought together experts from around the world to share knowledge and engage in discussion on all aspects of blood safety and haemovigilance.

For further info:
Programme

Day 1 presentations:

1.P. M. Placanica – The National System for Sentinel Event Reporting (SIMES)

1_PLACANICA

2.G. Forni – Supply of components for patients with haemoglobinopathies

2_FORNI

3.S. Vaglio – Haemoglobinopathies and thalassemia registry

3_VAGLIO

4.G. De Silvestro – Clinical implications of the Italian national register of therapeutic apheresis

4_DE_SILVESTRO

5.E. Petrisli – WHO NOTIFY 15 Year Anniversary

4_PETRISLI

6.I.Pati-V.Piccinini – Italian perspective on Haemovigilance and epidemiological surveillance

6_PATI_PICCININI

7.P.F. Toledo Barbosa – The Brazilian haemovigilance system

7_TOLEDO BARBOSA

8.I. Seferi – The Albanian haemovigilance system: Challenges and opportunities

8_SEFERI

10.C. Mikkelsen – Precision donor health: The future of donor vigilance?

10_MIKKELSEN

11.V. McDonald – Cyber security Case Study

11_MCDONALD

12.R. Goel – Haemovigilance and AI

12_GOEL

Day 2 presentations:

1.M. Haugen – The effect of plasma donation frequency on donor health and IgG levels

1_HAUGEN

2.V. Agostini – Delayed haemolytic transfusion reactions

2_AGOSTINI

3.D. Martino – From donation to lifelong treatment: Late but critical risks of transfusion and plasma-derived therapies from the patient perspective

3_MARTINO

4.S.Brujins – Adverse reactions in donors

4_BRUIJNS

5.M. Claus – Vigilance in the new SoHO Regulation: Regulatory obligations for the actors involved

5_CLAUS

6.R.M. Grubovic Rastvorceva – EDQM: Role and targeted activities

6_GRUBOVIC RASTVORCEVA

7.F.X. Lamy – ECDC: Role and targeted activities

7_LAMY

8.A. Kelly – Paediatric Transfusion Safety: What 10 years of SHOT haemovigilance data tells us

8_KELLY

9.L. Teofili-C. Pellegrino-S. Nobile – Neonatal transfusion: Why adult standards leave neonates behind

9_TEOFILI_PELLEGRINO_NOBILE

11.A. Agarwal – Perioperative Red Blood Cell Transfusion and Association with Postoperative Sepsis in a North American Prospective Registry: Is it a Hemovigilance Alert?

11_AGARWAL

12.A. Asante – Platelets, The Good, The Bad and The Ugly

12_ASANTE

13.M. Feltkamp – Climate change and emerging infectious diseases

13_FELTKAMP

14.O.B. Vesterager Pedersen – Environmental contaminants e.g. PFAS

14_PEDERSEN

15.A. Eder – Transfusion-transmitted Malaria and Hemovigilance in the US

15_EDER

Day 3 presentations:

1.P.C. Spinella – Increased use of LTOWB in RhD-negative women and alloimmunisation

1_SPINELLA

2.L. Green – SWIFT Trial

2_GREEN

3.M. Gybel-Brask – Freeze dried plasma in a preclinical setting – The Danish experience

3_GYBEL_BRASK

4.E. Klæboe Kristoffersen – Cold-stored platelets; the Norwegian experience

4_KRISTOFFERSEN

5.A. Oates – Just culture

5_OATES

6.E Milser – Lessons from Human Factors and Ergonomics Principles in Transfusion IT

6_MILSER

7.V. Rosa – Tracing blood transfusion: Findings from the global survey

7_ROSA